Cargando…
Differential Diagnosis of Cystic Pancreatic Lesions Including the Usefulness of Biomarkers
BACKGROUND: Cystic pancreatic lesions are more and more often found. Malignant risk ranges from nil to more than 60%. A precise diagnosis is required to adapt surveillance or therapeutic strategy. METHODS: We tried to identify the most difficult differential diagnoses encountered in a tertiary cente...
Autores principales: | Lévy, Philippe, Rebours, Vinciane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger Verlag für Medizin und Naturwissenschaften GmbH
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433139/ https://www.ncbi.nlm.nih.gov/pubmed/26285674 http://dx.doi.org/10.1159/000371786 |
Ejemplares similares
-
Biochemical Intracystic Biomarkers in the Differential Diagnosis of Pancreatic Cystic Lesions
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022) -
Radiomics for the Diagnosis and Differentiation of Pancreatic Cystic Lesions
por: Machicado, Jorge D., et al.
Publicado: (2020) -
Advances in the Diagnosis of Pancreatic Cystic Lesions
por: Pușcașu, Claudia Irina, et al.
Publicado: (2022) -
Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process
por: Faille, Dorothée, et al.
Publicado: (2018) -
Hypoxia Pathways and Cellular Stress Activate Pancreatic Stellate Cells: Development of an Organotypic Culture Model of Thick Slices of Normal Human Pancreas
por: Rebours, Vinciane, et al.
Publicado: (2013)